“Long-Term Trends of Psychotropic Drug Use in Nursing Homes,” (OEI-07-20-00500, November 2022, .pdf format, 31p.).
November 17, 2022
CAAR – US Department of Health and Human Services, Office of the Inspector General Report – November 17, 2022
April 21, 2022
CAAR – US Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation Report, Issue Brief – April 21, 2022
A. “Changes in Ownership of Hospital and Skilled Nursing Facilities: An Analysis of Newly-Released CMS Data,” by Pete Welch, Joel Ruhter, Arielle Bosworth, Nancy De Lew, and Benjamin D. Sommers (April 2022, .pdf format, 9p.).
aspe.hhs.gov/reports/changes-ownership-hospital-skilled-nursing-facilities
B. “Antipsychotic Medication Prescribing in Long Term Care Facilities Increased in the Early Months of the COVID-19 Pandemic,” by Iara Oliveira, Martin Blanco, and Mir Ali (April 2022, .pdf format, 14p.).
October 21, 2021
CAAR – Public Library of Science (PLoS) Article – October 21, 2021
“Mortality in association with antipsychotic medication use and clinical outcomes among geriatric psychiatry outpatients with COVID-19,” by Bienvenida Austria, Rehana Haque, Sukriti Mittal, Jamie Scott, Aninditha Vengassery, Daniel Maltz, Wentian Li, Blaine Greenwald, and Yun Freudenberg-Hua (PLoS ONE 16(10): e0258916. doi.org/10.1371/journal.pone.0258916, XML, HTML, and .pdf format, 10p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0258916
May 6, 2021
CAAR – US Department of Health and Human Services, Office of the Inspector General Report – May 6, 2021
“CMS Could Improve the Data It Uses To Monitor Antipsychotic Drugs in Nursing Homes,” (OEI-07-19-00490, May 2021, .pdf format, 22p.).
April 30, 2018
CAAR – AARP Public Policy Institute Reports – April 30, 2018
A. “Off-Label Antipsychotic Use in Older Adults with Dementia: Not Just a Nursing Home Problem,” by Elizabeth A. Carter (April 2018, .pdf format, 4p.).
www.aarp.org/ppi/info-2018/off-label-antipsychotic-use-in-older-adults-with-dementia.html
B. “Supplemental Nutrition Assistance Program Provides Benefits for Millions of Adults Ages 50 and Older,” by Olivia Dean and Lynda Flowers (April 2018, .pdf format, 9p.).
www.aarp.org/ppi/info-2018/snap-provides-benefits-for-millions-of-adults-ages-50-and-older.html
August 3, 2017
CAAR – US Centers for Medicare and Medicaid Services Report – August 3, 2017
“National Partnership to Improve Dementia Care in Nursing Homes: Antipsychotic Medication Use Data Report,” (July 2017, .pdf format, 3p.).
February 29, 2016
CAAR – Canadian Institute for Health Information/Institut Canadien D’information Sur La Sante Report- February 29, 2016
“Use of Antipsychotics Among Seniors Living in Long-Term Care Facilities, 2014,” (February 2016, .pdf format, 26p.).
secure.cihi.ca/estore/productFamily.htm?locale=en&pf=PFC3094
March 19, 2015
CAAR – Public Library of Science (PLoS) Article – March 19, 2015
“Risk of Ischemic Stroke Associated with the Use of Antipsychotic Drugs in Elderly Patients: A Retrospective Cohort Study in Korea,” by Ju-Young Shin, Nam-Kyong Choi, Joongyub Lee, Jong-Mi Seong, Mi-Ju Park, Shin Haeng Lee, and Byung-Joo Park (PLoS ONE 10(3): e0119931. doi:10.1371/journal.pone.0119931, XML, HTML, and .pdf format, 15p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0119931
March 2, 2015
CAAR – US Government Accountability Office Report – March 2, 2015
“Antipsychotic Drug Use: HHS Has Initiatives to Reduce Use among Older Adults in Nursing Homes, but Should Expand Efforts to Other Settings,” (GAO-15-211, January 2015, .pdf format, 50p.).
March 26, 2014
CAAR – Alzheimer’s Australia Report – March 26, 2014
“The Use of Restraint and Psychotropic Medication in People with Dementia,” by Carmelle Peisah and Dr. Ellen Skladzien (March 2014, .pdf format, 34p.).
January 14, 2014
CAAR – Public Library of Science (PLoS) Article – January 14, 2014
“Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer’s Disease: A National Population Cohort Study,” by Danijela Gnjidic, Sarah N. Hilmer, Sirpa Hartikainen, Anna-Maija Tolppanen, Heidi Taipale, Marjaana Koponen, and J. Simon Bell (PLoS ONE 9(1): e83224. doi:10.1371/journal.pone.0083224, XML, HTML, and .pdf format, 8p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0083224
May 16, 2013
CAAR – Public Library of Science (PLoS) Articles – May 16, 2013
A. “Diagnostic Value of the Impairment of Olfaction in Parkinson’s Disease,” by Swaantje Casjens, Angelika Eckert, Dirk Woitalla, Gisa Ellrichmann, Michael Turewicz, Christian Stephan, Martin Eisenacher, Caroline May, Helmut E. Meyer, Thomas Bruning, and Beate Pesch (PLoS ONE 8(5): e64735. doi:10.1371/journal.pone.0064735, XML, HTML, and .pdf format, 7p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0064735
B. “Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study,” by Irina Vasilyeva, Robert G. Biscontri, Murray W. Enns, Colleen J. Metge, and Silvia Alessi-Severini (PLoS ONE 8(5): e64217. doi:10.1371/journal.pone.0064217, XML, HTML, and .pdf format, 7p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0064217
C. “Intravenous Immunglobulin Binds Beta Amyloid and Modifies Its Aggregation, Neurotoxicity and Microglial Phagocytosis In Vitro,” by Susann Cattepoel, Alexander Schaub, Miriam Ender, Annette Gaida, Alain Kropf, Ursula Guggisberg, Marc W. Nolte, Louis Fabri, Paul A. Adlard, David I. Finkelstein, Reinhard Bolli, and Sylvia M. Miescher (PLoS ONE 8(5): e63162. doi:10.1371/journal.pone.0063162, XML, HTML, and .pdf format, 14p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063162
July 10, 2012
CAAR – US Department of Health and Human Services, Office of Inspector General Report – July 9, 2012
“Nursing Facility Assessments and Care Plans for Residents Receiving Atypical Antipsychotic Drugs,” (OEI-07-08-00151, July 2012, .pdf format, 31p.).